摘要
目的:研究人可溶性IL6R(hsIL6R)的空间构效关系,为小分子拮抗剂设计提供理论依据。方法:首先利用PCR技术扩增天然人sIL6R基因片段,然后将第280位His残基突变成Ile。天然基因和突变体基因分别转染COS7细胞,经ELISA和Westernblot检测证实转染细胞上清中的表达产物,并利用BindingasayELISA和生物学功能分析法检测表达产物与IL6的结合能力以及它们所介导的IL6信号转导功能的差异。结果:突变体H280I比天然sIL6R具有更高的IL6结合能力,但拮抗IL6在两种效应细胞系上的信号传递功能。结论:第280位His残基对sIL6R发挥正常生物学功能具有重要影响,是符合拮抗剂设计要求的一个很好的候选位点。
Objective:To study the structure function relationship of human soluble IL 6 receptor(hsIL 6R) and lay a foundation to design the antagonists.Methods:The sIL 6R gene was obtained by PCR and then histine 280 was mutanted into isolucine with site directed mutagenesis system.The expression plasmids of the two genes were introduced into COS7 cells and then the expressed products were confirmed by ELISA and Western blot.IL 6 binding abilities were measured by binding assay ELISA.The biological function analysis of the expressed products on the IL 6 responsive cells indicated their different abilities of signal transduction.Results:The mutant H280I had higher IL 6 binding ability than that of wtsIL 6R,but showed antagonistic function on IL 6 signal transdution.Conclusion:H280 played an important role in the function of sIL 6R and might be used as a target site for the antagonist design.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
1999年第5期203-206,共4页
Chinese Journal of Immunology
基金
国家自然科学基金